106 research outputs found

    Single CuO Nanowires Electrical Properties and Application on Photoelectrochemical Water Splitting

    Get PDF
    Charge transport in single crystal, p type copper oxide (CuO) nanowires (NWs) was studied through temperature based (120 K – 400 K) current-voltage (I-V) measurements of 2-terminal single NW devices. Individual CuO NWs with an average diameter of 220 nm were attached to Au electrodes 2.5 µm apart, using a dielectrophoresis method. I-V curves showed a transition from linear behavior at low bias to strong power law dependence (I ~ Va) at high bias, which can be attributed to space charge limited current (SCLC) mechanism. At low electrical fields (\u3c 0.89 × 103 V·cm-1), the number of injected charges was smaller than the number of free charge carriers inside the intrinsic p type CuO NW, resulting in Ohmic conduction. The thermal conductivity activation energy was calculated from the linear I-V curves to be 272 meV, and a thermal equilibrium hole concentration (peff) of 1.5 × 1016 cm-3 was obtained from the Ohmic regime. At higher electrical fields (\u3e 0.89 × 103 V·cm-1), the number of injected charges exceeded the number of free charge carriers, and the localized space charge moved from one site to another under the electrical field in discrete jumps, resulting in space charge limited current. Our results showed that there were exponentially distributed trap states in the CuO NWs (a\u3e2). As the free holes were trapped, current caused by the flow of holes was dictated by the density and energy distribution of the trap states. Study of the SCLC regime allowed further understanding of the trap states in CuO nanowires, which has not been reported until now. We obtained an average trap energy (ET) = 26.6 meV and trap density, NT = 3.4 × 1015cm-3. The charge carrier mobility was very low (\u3c 0.01 cm2/V·sec), as expected for the small polaron type reported for CuO. Furthermore, the small polaron mobility was found to be dominated by phonon scattering at low temperature and thermally activated hopping mechanism at high temperature. At temperatures higher than 210 K, small polarons started hopping, and the activation energy for hopping mobility was estimated to be 44 meV. The second part of the thesis focused on the photoelectrochemical water splitting application of electrodes fabricated using CuO nanowires. The valence band edge of CuO nanowires was found to be 4.93 eV below the vacuum level through the Mott Schottky test. Combining the experimental results from single nanowire 2-terminal devices and the Mott Schottky test, the band structure of the CuO nanowires was calculated. A photocurrent density of 0.75 mA·cm-2 was observed at a bias of -0.3 V vs. Ag/AgCl. The transient chopping light measurement indicated CuO nanowires had a strong resistance to photocorrosion under the testing conditions. Incident photon-to-current efficiency spectrum showed a peak value of 5 % at 430 nm, with a broad band photoresponse from the UV to near IR region due to the low bandgap (1.4 eV) of CuO. Based on our study, CuO nanowires are one of the promising water splitting photocathode materials despite the low intrinsic carrier concentration and mobility, mainly due to its one dimensional geometry and single crystal nature

    Coal Ignition Temperature in Oxygen-Enriched CFB Boiler

    Get PDF
    The oxygen-enriched Circulating fluidized bed (CFB) combustion technology is a new method to reduce CO2 emissions. The coal ignition temperature, Ti F, in an oxygen-enriched CFB boiler is an important parameter for designing the startup burner and for choosing the operating strategy during the startup process. The combustion of five types of coal under four different atmospheres (air, O2 27 %, O2 40%, O2 53%, CO2 as balance gas) was measured in a laboratory scale fluidized bed (FB) with an under-bed preheat system. Using thermocouples and a Gas Analyzer, the changes in bed temperature and the concentration of the different components, such as O2, CO2 and CO, in flue gas were directly measured to determine Ti F. It was found that Ti F decreased with increasing O2 concentration. The differences between the ignition temperatures determined in air and with 27 % O2 were not significant. At lower bed temperatures, for two coal types with higher volatiles, a two stage-ignition for volatiles and char was observed under a high O2 concentration. The time delay between the two stages decreased and finally merged into one with increasing bed temperature. Similar results were obtained in air. The coal with the higher volatile content had a lower ignition temperature in an oxygen-enriched CFB. Comparison of the ignition temperatures obtained by different methods and the feed temperatures in industrial CFB boilers showd that the measured result in a fluidized bed can be used as a reference for oxygen-enriched CFB boilers

    RUNDC3A regulates SNAP25-mediated chemotherapy resistance by binding AKT in gastric neuroendocrine carcinoma (GNEC)

    Get PDF
    Gastric neuroendocrine carcinoma (GNEC) is a common type of neuroendocrine carcinoma (NEC) with a poor prognosis and limited therapeutic options. The underlying mechanisms of chemoresistance in patients with GNEC and those with NEC are largely unknown, and thus, reliable biomarkers and therapeutic targets that could improve treatment outcomes in patients with NECs are lacking. The aim of this study was to identify specific targets and investigate their roles in GNEC progression and treatment resistance. Differentially expressed genes (DEGs) were identified in GNEC specimens and were further analysed by focusing on their roles in chemoresistance. Gene Ontology (GO) and pathway enrichment analyses of GNEC DEGs revealed that synapse-related function was the most prominent cellular function perturbed in GNEC. SNAP25 was identified as the target gene involved in most of the enriched pathways. In vitro and in vivo experiments showed that SNAP25 plays a role in proliferation and chemoresistance in GNEC cell lines. AKT has been identified as a downstream target, and SNAP25 binds to AKT protein and promotes AKT protein half-life. Further analysis of other types of NEC as well as small cell lung cancer, which resembles NEC on a molecular level, has identified RUNDC3A as an upstream molecule that regulates SNAP25 expression and the associated phenotypes that could enhance chemoresistance in NECs. Our results show that SNAP25 expression in GNEC is mediated by RUNDC3A and promotes GNEC progression and chemoresistance via posttranslational modification of AKT. Thus, our results suggest that the RUNDC3A/SNAP25/Akt axis could be a potential therapeutic target in GNEC

    An examination of Alzheimer’s disease and white matter from 1981 to 2023: a Bibliometric and visual analysis

    Get PDF
    BackgroundAlzheimer’s disease (AD) is characterized by the presence of gray matter lesions and alterations in white matter. This study aims to investigate the research related to white matter in the context of AD from a Bibliometric standpoint.MethodsRegular and review articles focusing on the research pertaining to Alzheimer’s disease (AD) and white matter were extracted from the Web of Science Core Collection (WOSCC) database, covering the period from its inception to 10th July 2023. The “Bibliometrix” R package was employed to summarize key findings, to quantify the occurrence of top keywords, and to visualize the collaborative network among countries. Furthermore, VOSviewer software was utilized to conduct co-authorship and co-occurrence analyses. CiteSpace was employed to identify the most influential references and keywords based on their citation bursts. The retrieval of AD- and white matter-related publications was conducted by the Web of Science Core Collection. Bibliometric analysis and visualization, including the examination of annual publication distribution, prominent countries, active institutions and authors, core journals, co-cited references, and keywords, were carried out by using VOSviewer, CiteSpace, the Bibliometrix Package, and the ggplot2 Package. The quality and impact of publications were assessed using the total global citation score and total local citation score.ResultsA total of 5,714 publications addressing the intersection of Alzheimer’s disease (AD) and white matter were included in the analysis. The majority of publications originated from the United States, China, and the United Kingdom. Prominent journals were heavily featured in the publication output. In addition to “Alzheimer’s disease” and “white matter,” “mild cognitive impairment,” “MRI” and “atrophy” had been frequently utilized as “keywords.”ConclusionThis Bibliometric investigation delineated a foundational knowledge framework that encompasses countries, institutions, authors, journals, and articles within the AD and white matter research domain spanning from 1981 to 2023. The outcomes provide a comprehensive perspective on the broader landscape of this research field

    Unbiased Analysis of Temporal Changes in Immune Serum Markers in Acute COVID-19 Infection With Emphasis on Organ Failure, Anti-Viral Treatment, and Demographic Characteristics

    Get PDF
    Identification of novel immune biomarkers to gauge the underlying pathology and severity of COVID-19 has been difficult due to the lack of longitudinal studies. Here, we analyzed serum collected upon COVID-19 admission (t1), 48 hours (t2), and seven days later (t3) using Olink proteomics and correlated to clinical, demographics, and therapeutic data. Older age positively correlated with decorin, pleiotrophin, and TNFRS21 but inversely correlated with chemokine (both C-C and C-X-C type) ligands, monocyte attractant proteins (MCP) and TNFRS14. The burden of pre-existing conditions was positively correlated with MCP-4, CAIX, TWEAK, TNFRS12A, and PD-L2 levels. Individuals with COVID-19 demonstrated increased expression of several chemokines, most notably from the C-C and C-X-C family, as well as MCP-1 and MCP-3 early in the course of the disease. Similarly, deceased individuals had elevated MCP-1 and MCP-3 as well as Gal-9 serum levels. LAMP3, GZMB, and LAG3 at admission correlated with mortality. Only CX3CL13 and MCP-4 correlated positively with APACHE score and length of stay, while decorin, MUC-16 and TNFRSF21 with being admitted to the ICU. We also identified several organ-failure-specific immunological markers, including those for respiratory (IL-18, IL-15, Gal-9) or kidney failure (CD28, VEGF). Treatment with hydroxychloroquine, remdesivir, convalescent plasma, and steroids had a very limited effect on the serum variation of biomarkers. Our study identified several potential targets related to COVID-19 heterogeneity (MCP-1, MCP-3, MCP-4, TNFR superfamily members, and programmed death-ligand), suggesting a potential role of these molecules in the pathology of COVID-19

    Case report:TP53 and RB1 loss may facilitate the transformation from lung adenocarcinoma to small cell lung cancer by expressing neuroendocrine markers

    Get PDF
    INTRODUCTION: Transformation from lung adenocarcinoma (LUAD) to small cell lung cancer (SCLC) is one of the mechanisms responsible for acquired EGFR-TKIs resistance. Although it rarely happens this event determines a rapid disease deterioration and needs specific treatment. PATIENT AND METHOD: We report a case of 75-year-old LUAD female with a p.L858R mutation in Epidermal Growth Factor Receptor (EGFR) who presented with SCLC transformation after responding to first line osimertinib treatment for only 6 months. To understand the underlying molecular mechanism, we retrospectively sequenced the first (LUAD) and the second (SCLC) biopsy using a 56 multi-gene panel. Immunohistochemistry (IHC) staining and Fluorescence In Situ Hybridization (FISH) was applied to confirm the genetic aberrations identified. RESULTS: EGFR p.E709A and p.L858R, Tumor Protein p53 (TP53) p.A159D and Retinoblastoma 1 (RB1) c.365-1G>A were detected in both the diagnostic LUAD and transformed SCLC samples. A high copy number gain for Proto-Oncogene C-Myc (MYC) and a Phosphoinositide 3-Kinase Alpha (PIK3CA) p.E545K mutation were found in the transformed sample specifically. Strong TP53 staining and negative RB1 staining were observed in both LUAD and SCLC samples, but FISH only identified MYC amplification in SCLC tissue. CONCLUSION: We consider the combined presence of MYC amplification with mutations in TP53 and RB1 as drivers of SCLC transformation. Our results highlight the need to systematically evaluate TP53 and RB1 status in LUAD patients to offer a different therapeutic strategy

    Case report: TP53 and RB1 loss may facilitate the transformation from lung adenocarcinoma to small cell lung cancer by expressing neuroendocrine markers

    Get PDF
    IntroductionTransformation from lung adenocarcinoma (LUAD) to small cell lung cancer (SCLC) is one of the mechanisms responsible for acquired EGFR-TKIs resistance. Although it rarely happens this event determines a rapid disease deterioration and needs specific treatment.Patient and methodWe report a case of 75-year-old LUAD female with a p.L858R mutation in Epidermal Growth Factor Receptor (EGFR) who presented with SCLC transformation after responding to first line osimertinib treatment for only 6 months. To understand the underlying molecular mechanism, we retrospectively sequenced the first (LUAD) and the second (SCLC) biopsy using a 56 multi-gene panel. Immunohistochemistry (IHC) staining and Fluorescence In Situ Hybridization (FISH) was applied to confirm the genetic aberrations identified.ResultsEGFR p.E709A and p.L858R, Tumor Protein p53 (TP53) p.A159D and Retinoblastoma 1 (RB1) c.365-1G>A were detected in both the diagnostic LUAD and transformed SCLC samples. A high copy number gain for Proto-Oncogene C-Myc (MYC) and a Phosphoinositide 3-Kinase Alpha (PIK3CA) p.E545K mutation were found in the transformed sample specifically. Strong TP53 staining and negative RB1 staining were observed in both LUAD and SCLC samples, but FISH only identified MYC amplification in SCLC tissue.ConclusionWe consider the combined presence of MYC amplification with mutations in TP53 and RB1 as drivers of SCLC transformation. Our results highlight the need to systematically evaluate TP53 and RB1 status in LUAD patients to offer a different therapeutic strategy
    • …
    corecore